Ex-FDA neu­ro chief Bil­ly Dunn is tak­ing a spin through the re­volv­ing door with bio­phar­ma — and that's a prob­lem

It’s been less than three months since the FDA put out word that Bil­ly Dunn had left the agency fol­low­ing a con­tro­ver­sial run high­light­ed by …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.